SEB Asset Management AB Buys Shares of 503,534 Oscar Health, Inc. $OSCR

SEB Asset Management AB purchased a new stake in Oscar Health, Inc. (NYSE:OSCR) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 503,534 shares of the company’s stock, valued at approximately $5,776,000.

Several other hedge funds have also made changes to their positions in the company. Thrive Capital Management LLC raised its position in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after buying an additional 1,588,395 shares during the period. Baird Financial Group Inc. purchased a new position in Oscar Health in the first quarter worth approximately $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Oscar Health by 4.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock worth $2,827,000 after acquiring an additional 8,879 shares during the period. Jones Financial Companies Lllp increased its stake in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Oscar Health by 39.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock worth $6,169,000 after acquiring an additional 132,149 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Insider Transactions at Oscar Health

In other Oscar Health news, Director Mario Schlosser sold 880,000 shares of the business’s stock in a transaction dated Tuesday, June 23rd. The shares were sold at an average price of $29.38, for a total transaction of $25,854,400.00. Following the sale, the director directly owned 480,866 shares in the company, valued at $14,127,843.08. This represents a 64.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Richard Scott Blackley sold 100,000 shares of the stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the sale, the chief financial officer directly owned 1,216,660 shares in the company, valued at $28,177,845.60. This represents a 7.59% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 3,662,466 shares of company stock worth $105,145,815 in the last 90 days. Insiders own 22.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on OSCR shares. Zacks Research raised Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. Wells Fargo & Company set a $20.00 price objective on Oscar Health and gave the stock an “equal weight” rating in a research report on Thursday, June 4th. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Jefferies Financial Group raised shares of Oscar Health from an “underperform” rating to a “hold” rating and upped their target price for the company from $10.00 to $16.00 in a research report on Monday, April 20th. Finally, UBS Group increased their target price on shares of Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Oscar Health has a consensus rating of “Hold” and an average target price of $20.78.

Oscar Health Stock Down 4.1%

Shares of NYSE OSCR opened at $29.50 on Thursday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The business’s 50 day moving average is $27.33 and its two-hundred day moving average is $19.31. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $33.10. The firm has a market cap of $8.89 billion, a price-to-earnings ratio of -50.00, a PEG ratio of 1.72 and a beta of 2.34.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping the consensus estimate of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. During the same period last year, the business posted $0.92 earnings per share. The company’s quarterly revenue was up 52.6% on a year-over-year basis. Research analysts predict that Oscar Health, Inc. will post 0.59 EPS for the current year.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.